Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A02 DRUGS FOR ACID RELATED DISORDERS
A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
A02BD Combinations for eradication of Helicobacter pylori
A02BD03 Lansoprazole, amoxicillin and metronidazole
D09742 Lansoprazole, amoxicillin hydrate and metronidazole
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01R COMBINATIONS OF ANTIBACTERIALS
J01RA Combinations of antibacterials
J01RA01 Penicillins, combinations with other antibacterials
D09742 Lansoprazole, amoxicillin hydrate and metronidazole
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D09742 Lansoprazole, amoxicillin hydrate and metronidazole
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09742 Lansoprazole, amoxicillin hydrate and metronidazole
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Combination for eradication of H. pylori
D09742 Lansoprazole, amoxicillin hydrate and metronidazole
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09742